Pharmacy-mediated substitution of biosimilars – a global survey benchmarking country substitution policies

Author(s): Hannah Larkin, Judith Macdonald, Rebecca Lumsden, PhD

Introduction/Study objectives: Between March and May 2017, Pfizer conducted an internal global survey of 82 countries examining biosimilar pharmacy-mediated substitution to understand and benchmark the global policy landscape. Methods: Pfizer regulatory and corporate affairs colleagues completed a survey: Are pharmacists in your country able to substitute a biological with a biosimilar without the physician being […]

Read more →